Comparison of Left Ventricular Mass Index and Prolonged QTInterval in Type 2 Diabetic Patients
Abstract
To compare left ventricular mass index and QT interval in type 2 diabetic and non-diabetic patients.
108 patients with 54 in each group were inducted. Group A (case) were diabetic type 2 and group B (control)
were non-diabetic. The study was conducted in the medicine department of Lahore General hospital.
In this study, the mean age in diabetic and non-diabetic subjects was 47.54 ± 9.25 and 44.53 ± 10.53 respectively
with no significant difference, p-value = 0.199. In the diabetic group, there were 29 (53.70%) males and 25 (46.30%)
females while in the non-diabetic group there were 27 (50%) male and 27 (50%) female patients. The mean LVMI in
diabetic patients was significantly higher (129.48±30.72) as compared to control (49.30) with p-value<0.001. The mean
QT in diabetic and non-diabetic was 431.65ms and 387.33ms while corrected QT interval was 468.31ms and 413.37ms
respectively.
The results of this study suggest that both LVMI and QT interval are higher in diabetic population when
compared to non-diabetic subjects. Early screening and proper diagnosis must be adopted in type 2 diabetic patients as
they are very prone to develop higher left ventricular mass and deranged QT interval can further lead to significant
cardiovascular risk because left ventricular hypertrophy and deranged QT interval are absolute risk factors for ventricular
arrhythmia, infarction of myocardium, coronary artery disease, cardiac failure and sudden mortality.
How to Cite This Article
Raffad R, Kamal A, Meherjan D, Malik K, Ahmad A. Comparison of Left Ventricular Mass Index and Prolonged QTInterval in Type 2 Diabetic Patients. J Pak Soc Intern Med. 2024;5(4):694–698. doi:10.70302/jpsim.v5i4.2466
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complications. 2012; 26: 10-16.
- Mwangi, T. (2000). The burden of diabetes in Africa: A review. Tropical Doctor, 30(3), 159-162.
- AS Shera, FJawad, A Maqsood May 2007, 76(219-222)
- Krolewski, A. S., Laffel, L. M., Krolewski, M., Quinn, M., & Warram, J. H. (1987). Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. The New England Journal of Medicine, 317(26), 1556-1560.
- Barr C, Naas A, Freeman M, Lang C, Struthers A. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994; 343: 327-329.
- Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986; 111: 383-390.
- Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322: 1561-1566.
- Manolio TA, Levy D, Garrison RJ, Castelli WP, Kannel WB. Relation of alcohol intake to left ventricular mass: The Framingham Study. J Am Coll Cardiol. 1991; 17: 717-721.
- Malmberg, K., & Ryden, L. (1988). Myocardial infarction and diabetes: An overview. European Heart Journal, 9(3), 293-298.
- Herlitz, J., Hjalmarson, A., Lamm, C., & Ryden, L. (1988). Mortality and morbidity during a five-year follow-up of diabetics with acute myocardial infarction. European Heart Journal, 9(10), 1056-1061.
- Bertoni, A. G., Goff, D. C., D'Agostino, R. B., Ramachandran, V. S., & Mukamal, K. J. (2003). Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis. Diabetes Care, 26(1), 166-171.
- Santra, S., Das, M., and Mukherjee, S. (2011). Diabetes and Cardiovascular Risk. Journal of Medical Research, 45(3), 123-130.
- Miki T, Tobisawa T, Sato T, Tanno M, Yano T, Akasaka H, et al. Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes? Cardiovascular diabetology. 2014; 13: 125.
- Veglio, M., Bruno, G., Cavallo-Perin, P., and Pagano, G. (2002). Diabetes, hypertension, and Atherosclerosis Study Group. Lowered baroreflex sensitivity in primary hypertension. Clin Sci (Lond) 103(5), 521-526.
- Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine–isosorbide dinitra
- Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M, et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol. 2001; 87: 1260-1265.
- Kuperstein R, Hanly P, Niroumand M, Sasson Z. The importance of age and obesity on the relation between diabetes and left ventricular mass. J Am Coll Cardiol. 2001; 37: 1957-1962.
- Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects hypertension genetic epidemiology network (HyperGEN) study. Circulation. 2001; 103: 102-107.
- Pengkaew P, Choon–Ngarm T, Deerochanawang C. Prevalence of left ventricular hypertrophy in patients with normotensive type 2 diabetes mellitus. Thai Heart J. 2007; 20: 142-149.
- Naas AA, Davidson NC, Thompson C, Cummings F, Ogston SA, Jung RT, et al. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. Bmj. 1998; 316: 745-746.
- Mahgoub MA, Abd-Elfattah AS. Diabetes mellitus and cardiac function. Mol Cell Biochem. 1998; 180: 59-64.
- Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali JK. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. Jama. 1995; 273: 1592-1597.
- Ahmed SS, Jaferi GA, Narang RM, Regan TJ. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J. 1975; 89: 153-158.
- Grossman, A., Grossman, E., Goldstein, D., & Linn, T. (1992). Management of diabetes mellitus. Oxford University Press.
- Devereux, R. B., & Alderman, M. H. (1993). Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation, 88(4), 1444-1455.
- Bonakdar, Z. S., Kambal, A. P., Mohammad, F. T., & Farokhi, F. (2014). Diabetes management: Time to choose safe and effective alternative medicine. International Journal of Preventive Medicine, 5(12), 1559–1564.
- Timar, R., Timar, B., & Dulf, D. (2013). Impaired glucose metabolism and diabetes in heart failure. European Journal of Heart Failure, 15(6), 577–589.
- Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005 Mar;54(11):3252-7.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.